Real-time enrollment status for this pancreatic cancer metastatic clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 5:28 PM UTC
| NCT Number | NCT06030622 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Cancer Metastatic |
| Phase | PHASE1 |
| Target Enrollment | 25 participants |
| Active Locations | 1 sites in the US |
| Sponsor | State University of New York - Downstate Medical Center |
| Last Updated on CT.gov | August 3, 2026 (Aug 3, 2026) |
As of October 12, 2026: Clinical trial NCT06030622 is currently recruiting participants. This phase1 study for pancreatic cancer metastatic is actively seeking new participants at 1 location across the United States. The study is sponsored by State University of New York - Downstate Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06030622 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06030622 was last updated Aug 3, 2026 (August 3, 2026). HelloStudys verifies this status automatically.